News
Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
According to the Market Research Blog, "the total U.S. weight loss market is estimated to have grown to a historic peak of ...
The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or ...
11d
News-Medical.Net on MSNTirzepatide outperforms semaglutide for weight loss in people without diabetesA head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...
A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...
Explore more
In the first direct comparison study involving individuals with obesity, tirzepatide demonstrated approximately 50% greater ...
A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but ...
Wilde is getting more, and better, sleep now that his sleep apnea is under control, thanks to his CPAP machine and tirzepatide. Also known as Zepbound or Mounjaro, it's the same drug helping millions ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results